IDEX vs. CMAX, ICLK, SAI, FRSX, STBX, MTEK, AHI, OMH, MLGO, and TOMZ
Should you be buying Ideanomics stock or one of its competitors? The main competitors of Ideanomics include CareMax (CMAX), iClick Interactive Asia Group (ICLK), SAI.TECH Global (SAI), Foresight Autonomous (FRSX), Starbox Group (STBX), Maris-Tech (MTEK), Advanced Health Intelligence (AHI), Ohmyhome (OMH), MicroAlgo (MLGO), and TOMI Environmental Solutions (TOMZ). These companies are all part of the "business services" sector.
CareMax (NASDAQ:CMAX) and Ideanomics (NASDAQ:IDEX) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, community ranking, dividends, valuation and analyst recommendations.
In the previous week, CareMax had 4 more articles in the media than Ideanomics. MarketBeat recorded 6 mentions for CareMax and 2 mentions for Ideanomics. CareMax's average media sentiment score of 0.94 beat Ideanomics' score of 0.07 indicating that Ideanomics is being referred to more favorably in the news media.
65.9% of CareMax shares are owned by institutional investors. Comparatively, 4.4% of Ideanomics shares are owned by institutional investors. 26.9% of CareMax shares are owned by company insiders. Comparatively, 0.6% of Ideanomics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Ideanomics received 66 more outperform votes than CareMax when rated by MarketBeat users. Likewise, 68.81% of users gave Ideanomics an outperform vote while only 30.00% of users gave CareMax an outperform vote.
Ideanomics has lower revenue, but higher earnings than CareMax. CareMax is trading at a lower price-to-earnings ratio than Ideanomics, indicating that it is currently the more affordable of the two stocks.
CareMax has a net margin of -79.55% compared to CareMax's net margin of -931.66%. Ideanomics' return on equity of -57.78% beat CareMax's return on equity.
CareMax has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, Ideanomics has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
CareMax presently has a consensus price target of $45.00, suggesting a potential upside of 1,410.07%. Given Ideanomics' higher probable upside, equities analysts plainly believe CareMax is more favorable than Ideanomics.
Summary
CareMax beats Ideanomics on 9 of the 16 factors compared between the two stocks.
Get Ideanomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for IDEX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ideanomics Competitors List
Related Companies and Tools
